Literature DB >> 29518755

Diabetic nephropathy: is it always there? Assumptions, weaknesses and pitfalls in the diagnosis.

Kyriakos Ioannou1,2,3.   

Abstract

Diabetic nephropathy is defined as a microvascular complication of the kidneys induced by diabetes mellitus and is characterized by albuminuria and progressive loss of kidney function. However, neither albuminuria nor glomerular filtration rate decline are diabetic nephropathy-specific markers, thus the diagnosis of diabetic nephropathy greatly depends on assumptions. Several factors should be taken into account when urinary albumin levels are assessed before establishing the diagnosis of diabetic nephropathy, while newer more specific markers for diabetic nephropathy are urgently needed.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29518755     DOI: 10.14310/horm.2002.1755

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  15 in total

1.  Adipose mesenchymal stem cell-derived extracellular vesicles containing microRNA-26a-5p target TLR4 and protect against diabetic nephropathy.

Authors:  Yurui Duan; Qingyang Luo; Yun Wang; Yali Ma; Fang Chen; Xiaoguang Zhu; Jun Shi
Journal:  J Biol Chem       Date:  2020-06-24       Impact factor: 5.157

2.  Establishment and Validation of a Nomogram Model for Prediction of Diabetic Nephropathy in Type 2 Diabetic Patients with Proteinuria.

Authors:  Dong-Mei Zhou; Jing Wei; Ting-Ting Zhang; Feng-Jie Shen; Jin-Kui Yang
Journal:  Diabetes Metab Syndr Obes       Date:  2022-04-08       Impact factor: 3.168

3.  Mogroside IIIE Alleviates High Glucose-Induced Inflammation, Oxidative Stress and Apoptosis of Podocytes by the Activation of AMPK/SIRT1 Signaling Pathway.

Authors:  Wei Xue; Juhua Mao; Qingjie Chen; Weide Ling; Yuqi Sun
Journal:  Diabetes Metab Syndr Obes       Date:  2020-10-20       Impact factor: 3.168

Review 4.  Signal transduction mechanism of exosomes in diabetic complications (Review).

Authors:  Xueting Li; Shuo Shi; Dehuai Jing; Xinjian Li; Bin Zhang; Qingli Bie
Journal:  Exp Ther Med       Date:  2021-12-17       Impact factor: 2.447

5.  Effect of liraglutide on endoplasmic reticulum stress in the renal tissue of type 2 diabetic rats.

Authors:  Xuan-Ye Zhao; Ting-Ting Yu; Sheng Liu; Yao-Ji Liu; Jing-Jin Liu; Jie Qin
Journal:  World J Diabetes       Date:  2020-12-15

6.  A Non-Invasive Prediction Model for Non-Alcoholic Fatty Liver Disease in Adults with Type 2 Diabetes Based on the Population of Northern Urumqi, China.

Authors:  Mingyue Xue; Xiaoping Yang; Yuan Zou; Tao Liu; Yinxia Su; Cheng Li; Hua Yao; Shuxia Wang
Journal:  Diabetes Metab Syndr Obes       Date:  2021-02-02       Impact factor: 3.168

7.  Anthropometric Measures and Incident Diabetic Nephropathy in Participants With Type 2 Diabetes Mellitus.

Authors:  Daniel Nyarko Hukportie; Fu-Rong Li; Rui Zhou; Jia-Zhen Zheng; Xiao-Xiang Wu; Xian-Bo Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-04       Impact factor: 5.555

8.  Association of Predicted Lean Body Mass and Fat Mass With Incident Diabetic Nephropathy in Participants With Type 2 Diabetes Mellitus: A Post Hoc Analysis of ACCORD Trial.

Authors:  Daniel Nyarko Hukportie; Fu-Rong Li; Rui Zhou; Meng-Chen Zou; Xiao-Xiang Wu; Xian-Bo Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-27       Impact factor: 5.555

9.  Complement C7 is Specifically Expressed in Mesangial Cells and is a Potential Diagnostic Biomarker for Diabetic Nephropathy and is Regulated by miR-494-3p and miR-574-5p.

Authors:  Hang Guo; Zhiyue Yan; Yonghui Hu; Xitong Huang; Congqing Pan
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-05       Impact factor: 3.168

10.  Loss of lncRNA MIAT ameliorates proliferation and fibrosis of diabetic nephropathy through reducing E2F3 expression.

Authors:  Ting-Ting Ji; Ying-Hui Qi; Xiao-Ying Li; Bo Tang; Ya-Kun Wang; Peng-Xi Zheng; Weiliang Li; Xiaolei Qu; Linhong Feng; Shou-Jun Bai
Journal:  J Cell Mol Med       Date:  2020-10-03       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.